Impact of calcineurin inhibitors on rat glioma cells viability |
Seong, Jeong Hun
(Department of Internal Medicine, Keimyung University School of Medicine)
Park, Woo Yeong (Department of Internal Medicine, Keimyung University School of Medicine) Paek, Jin Hyuk (Department of Internal Medicine, Keimyung University School of Medicine) Park, Sung Bae (Department of Internal Medicine, Keimyung University School of Medicine) Han, Seungyeup (Department of Internal Medicine, Keimyung University School of Medicine) Mun, Kyo-Cheol (Department of Biochemistry, Keimyung University School of Medicine) Jin, Kyubok (Department of Internal Medicine, Keimyung University School of Medicine) |
1 | Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002;346:580-90. DOI |
2 | Malvezzi P, Rostaing L. The safety of calcineurin inhibitors for kidney-transplant patients. Expert Opin Drug Saf 2015;14:1531-46. DOI |
3 | Burdmann EA, Andoh TF, Yu L, Bennett WM. Cyclosporine nephrotoxicity. Semin Nephrol 2003;23:465-76. DOI |
4 | Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009;4:481-508. DOI |
5 | Anghel D, Tanasescu R, Campeanu A, Lupescu I, Podda G, Bajenaru O. Neurotoxicity of immunosuppressive therapies in organ transplantation. Maedica (Buchar) 2013;8:170-5. |
6 | Senzolo M, Ferronato C, Burra P. Neurologic complications after solid organ transplantation. Transpl Int 2009;22:269-78. DOI |
7 | Besenski N, Rumboldt Z, Emovon O, Nicholas J, Kini S, Milutinovic J, et al. Brain MR imaging abnormalities in kidney transplant recipients. AJNR Am J Neuroradiol 2005;26:2282-9. |
8 | Coley SC, Porter DA, Calamante F, Chong WK, Connelly A. Quantitative MR diffusion mapping and cyclosporine-induced neurotoxicity. AJNR Am J Neuroradiol 1999;20:1507-10. |
9 | Schwartz RB, Bravo SM, Klufas RA, Hsu L, Barnes PD, Robson CD, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 1995;165:627-31. DOI |
10 | Oh YL, Han SY, Mun KH, Choi HJ, Kim HY, Hwang EA, et al. Cyclosporine-induced apoptosis in osteosarcoma cells. Transplant Proc 2006;38:2237-9. DOI |
11 | Han SY, Chang EJ, Choi HJ, Nam SI, Lee NH, Kwak CS, et al. Total antioxidant status and oxygen free radicals during hepatic regeneration. Transplant Proc 2006;38:2214-5. DOI |
12 | Hoorn EJ, Walsh SB, McCormick JA, Zietse R, Unwin RJ, Ellison DH. Pathogenesis of calcineurin inhibitor-induced hypertension. J Nephrol 2012;25:269-75. DOI |
13 | Chakkera HA, Mandarino LJ. Calcineurin inhibition and new-onset diabetes mellitus after transplantation. Transplantation 2013;95:647-52. DOI |
14 | Rosendal F, Bjarkam CR, Larsen M, Hansen HE, Madsen M, Sorensen JC, et al. Does chronic low-dose treatment with cyclosporine influence the brain? A histopathological study in pigs. Transplant Proc 2005;37:3305-8. DOI |
15 | Kiemeneij IM, de Leeuw FE, Ramos LM, van Gijn J. Acute headache as a presenting symptom of tacrolimus encephalopathy. J Neurol Neurosurg Psychiatry 2003;74:1126-7. DOI |
16 | Thompson CB, June CH, Sullivan KM, Thomas ED. Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet 1984;2:1116-20. |
17 | Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol 1999;246:339-46. DOI |
18 | Kou R, Greif D, Michel T. Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A. J Biol Chem 2002;277:29669-73. DOI |
19 | Jang YH, Lee YC, Park NH, Shin HY, Mun KC, Choi MS, et al. Polyphenol (-)-epigallocatechin gallate protection from ischemia/reperfusion-induced renal injury in normotensive and hypertensive rats. Transplant Proc 2006;38:2190-4. DOI |
20 | Han SY, Mun KC, Choi HJ, Kwak CS, Bae JH, Suh SI, et al. Effects of cyclosporine and tacrolimus on the oxidative stress in cultured mesangial cells. Transplant Proc 2006;38:2240-1. DOI |
21 | Folbergrova J, Li PA, Uchino H, Smith ML, Siesjo BK. Changes in the bioenergetic state of rat hippocampus during 2.5 min of ischemia, and prevention of cell damage by cyclosporin A in hyperglycemic subjects. Exp Brain Res 1997;114:44-50. DOI |
22 | Beal MF. Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1998;1366:211-23. DOI |
![]() |